Comparing weight loss medication plans after GLP-1 therapy
Part of Hormones & metabolism clinical trials.
This trial compares different ways to keep weight off after you've lost weight using a GLP-1 medication, like semaglutide or tirzepatide. It tests reducing your GLP-1 dose and adding other weight loss medications to help maintain your progress.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have obesity (BMI of 30 or higher) and have been on a GLP-1 weight loss medication (like semaglutide or tirzepatide) for at least 6 months.
- You have reached or are close to your target weight, having lost at least 5% of your starting weight.
- You do not have type 2 diabetes or heart disease.
- You are not pregnant, nursing, or planning to become pregnant in the next year.
- You have not had bariatric surgery and are willing to change your current GLP-1 dose or switch to another medication.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to manage weight: taking a GLP-1 medication (like tirzepatide or semaglutide) versus making lifestyle changes without medication. It will help researchers learn which approach works best for people with overweight or obesity.
This study tests whether slowly reducing the dose of the weight-loss medication semaglutide can help keep weight off after losing at least 10% of body weight. It compares two ways of tapering the dose to see which works better for maintaining weight loss.
This trial tests a special medical food to help keep muscle mass while losing weight with GLP-1 medications like liraglutide, semaglutide, or tirzepatide. It's for adults with obesity or overweight with related health issues.
This study tests whether two different diet plans can help people keep off the weight they lost after stopping a GLP-1 medication. You would follow one of two eating plans for a year to see which helps maintain weight loss.
This study tests a 6-month behavioral program to help people keep off the weight they lost using GLP-1 or other weight-loss medications after they stop taking those medications. The program includes a 10-week foundational course, virtual sessions, and support to help you maintain your weight loss.
This study tests whether a medication called semaglutide, which is used for weight loss, works better for people who also have binge eating. It aims to find the best treatment based on brain and behavior differences.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.